Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer.

Xiao-Li WeiJian-Ying XuDe-Sheng WangDong-Liang ChenChao RenJia-Ning LiFeng WangFeng-Hua WangRui-Hua Xu

Published in: Therapeutic advances in medical oncology (2021)

BLN, rather than factors regarding baseline tumor size, is perhaps a potential predictor for benefit from immunotherapy and its combination with TMB could further risk-stratify patients with AGC receiving immunotherapy.

Keyphrases

prognostic factors
squamous cell carcinoma
radiation therapy
risk assessment
human health